Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Middle Meningeal Artery Embolization on Recurrence and Functional Outcomes in Patients With Chronic Subdural Hematoma

NCT07806552 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07806552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07806552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Middle Meningeal Artery Embolization on Recurrence and Functional Outcomes in Patients With Chronic Subdural Hematoma
Lead sponsor
Assiut University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
February 28, 2029
Enrollment
35 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic subdural hematomas, middle meningeal artery embolization